These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Brain scintigraphy in the diagnosis of intracranial lesions. Comparative scanning with 169 ytterbium diethylenetriaminepenta-acetic acid and 203 mercury chlormerodrin. Jansen CR, Meyer BJ, Bieler EU, du Toit D. S Afr Med J; 1973 Feb 10; 47(6):232-6. PubMed ID: 4689009 [No Abstract] [Full Text] [Related]
6. Extravasation of pertechnetate in cranial extracerebral tissues during first pass across the cerebral vasculature. Bartolini A, Leonardi A, Albano A, Primavera A. Boll Soc Ital Biol Sper; 1983 Jan 31; 59(2):126-30. PubMed ID: 6305376 [Abstract] [Full Text] [Related]
7. [Radiation protection in cerebral diagnosis with various radionuclides]. Abraham K, Morczek A, Koch RD, Parnitzke KH. Psychiatr Neurol Med Psychol Beih; 1969 Jan 31; 10-11():104-10. PubMed ID: 4378042 [No Abstract] [Full Text] [Related]
8. Radiation dosimetry and chemical toxicity considerations for 99Tc. Coffey JL, Hayes RL, Rafter JJ, Watson EE, Carlton JE. Health Phys; 1984 Feb 31; 46(2):418-22. PubMed ID: 6319333 [No Abstract] [Full Text] [Related]
9. [Nephroscintigraphy using a commercially prepared 99m-technetium-iron complex]. Lütgemeir J, Wilhauck HG. Fortschr Geb Rontgenstr Nuklearmed; 1972 Feb 31; ():Suppl:167-8. PubMed ID: 4341074 [No Abstract] [Full Text] [Related]
11. Early behaviour of 99mTc-pertechnetate in the head after intravenous bolus injection: its relevance to the cerebral blood circulation. Keyeux A, Ochrymowicz-Bemelmans D. Eur J Nucl Med; 1983 Feb 31; 8(5):196-200. PubMed ID: 6307699 [Abstract] [Full Text] [Related]
12. Analysis of 96 abnormal brain scans using technetium 99m (pertechnetate form). Quinn JL, Ciric I, Hauser WN. JAMA; 1965 Oct 11; 194(2):157-60. PubMed ID: 5897319 [No Abstract] [Full Text] [Related]
13. Thyroid imaging agents: a comparison of I-123 and Tc-99m pertechnetate. Ryo UY, Vaidya PV, Schneider AB, Bekerman C, Pinsky SM. Radiology; 1983 Sep 11; 148(3):819-22. PubMed ID: 6308711 [Abstract] [Full Text] [Related]
14. [Results of experimental-clinical studies of Tc99m-pertechnetate]. Koval'chuk ND, Kotliarov EV, Sedov VV, Tarasov NF, Iudin LA. Med Radiol (Mosk); 1967 Dec 11; 12(12):21-6. PubMed ID: 5616283 [No Abstract] [Full Text] [Related]
15. [Comparative studies of brain scintigraphy using 99mTc-pertechnetate and 99mTc-diphosphonate]. Széplaki Z, Tóth G, Kovács L, Antóny M. Orv Hetil; 1982 Oct 24; 123(43):2655-6. PubMed ID: 6292813 [No Abstract] [Full Text] [Related]
17. Differences in choroid plexus concentration of pertechnetate produced by varying time of pertechnetate administration and brain imaging. Alazraki NP, Littenberg RL, Hurwitz S, Quinto RR, Halpern SE, Ashburn WL. J Nucl Med; 1974 Oct 24; 15(10):884-6. PubMed ID: 4370960 [No Abstract] [Full Text] [Related]
18. [Radionuclide study of thyroid function in pediatrics, using 99mTc, 123I or 131I: 150 case-reports (author's transl)]. Guillet J, Basse-Cathalinat B, Soubiran G, Guillet G, Blanquet P. Ann Pediatr (Paris); 1981 Nov 24; 28(9):621-6. PubMed ID: 6274241 [No Abstract] [Full Text] [Related]
19. [Determination of scattered radiation and optimum discriminator adjustment of a single-channel analyzer for brain and liver scintigrams using the radionuclide (99m)Tc]. Ertl S. Radiobiol Radiother (Berl); 1980 Nov 24; 21(6):832-40. PubMed ID: 6264541 [No Abstract] [Full Text] [Related]